Schrödinger
Computational platform for drug discovery and materials science.
Company facts
- Founded
- 1990
- Employees
- 1,015
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: SDGR
- Subsidiaries
- Schrödinger GmbH, Xtal BioStructures
About
Schrödinger’s computational platform, powered by physics, is transforming the way therapeutics and materials are discovered to make innovations of the future achievable, today. Schrödinger is the scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical, biotechnology, and materials research. Our mission is to improve human health and quality of life by transforming the way therapeutics and materials are discovered. We work across various sectors, leveraging our industry-leading platform to discover and optimize better molecules and materials. Our therapeutics group systematically reduces risk in drug discovery by targeting high-value opportunities validated by human genetics or clinical data. We also focus on streamlining the educational journey of professionals through resources developed by leaders in the field. Schrödinger stands committed to pushing the boundaries of computational chemistry and biomolecular design, thus paving the way for future advancements in therapeutics and material science.